Floatz logo

MEGESTROL ACETATE IMPURITY B

Cachexia

Changchun GeneScience Pharmaceutical Co., Ltd.Small moleculePhase 3Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Cachexia cohort.

Asset / SponsorPhaseRating
Anamorelin
Helsinn Therapeutics (U.S.), Inc
Phase 3BB
Ponsegromab
Pfizer
Phase 2/3BB
Nanocrystalline Megestrol Acetate Suspension
Nanfang Hospital, Southern Medical University
Phase 3BB
Infliximab
Centocor, Inc.
Phase 3BB
1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER
Mayo Clinic
Phase 3B

View all 29 →

Same molecule, other indications

MEGESTROL ACETATE IMPURITY B is also rated in:

breast carcinomaDormant
BB
Indicative ·
70 / 100
View asset →
HIV wasting syndromeDormant
BB
Indicative ·
68 / 100
View asset →
AnorexiaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →